Gene Therapy Approaches in an Autoimmune Demyelinating Disease: Multiple Sclerosis

Abstract

Multiple Sclerosis (MS) is the most common autoimmune demyelinating disease of the Central Nervous System (CNS). It is a multifactorial disease which develops in an immune-mediated way under the influences of both genetic and environmental factors. Demyelination is observed in the brain and spinal cord leading to neuro-axonal damage in patients with MS. Due to the infiltration of different immune cells such as T-cells, B-cells, monocytes and macrophages, focal lesions are observed in MS. Currently available medications treating MS are mainly based on two strategies; i) to ease specific symptoms or ii) to reduce disease progression. However, these medications tend to induce different adverse effects with limited therapeutic efficacy due to the protective function of the blood-brain barrier. Therefore, researchers have been working for the last four decades to discover better solutions by introducing gene therapy approaches in treating MS generally by following three strategies, i) prevention of specific symptoms, ii) halt or reverse disease progression and iii) heal CNS damage by promoting remyelination and axonal repair. In last two decades, there have been some remarkable successes of gene therapy approaches on the experimental mice model of MS - experimental autoimmune encephalomyelitis (EAE) which suggests that it is not far that the gene therapy approaches would start in human subjects ensuring the highest levels of safety and efficacy. In this review, we summarised the gene therapy approaches attempted in different animal models towards treating MS.

Comprehensive Analysis Revealed that CDKN2A is a Biomarker for Immune Infiltrates in Multiple Cancers

“…The tumor microenvironment contains two components, immune and stromal cells, which possess diagnostic and prognostic value in cancers ( Hanahan and Weinberg, 2011 ; Fridman et al, 2012 ; Zhang et al, 2019 ; Hu et al, 2020 ; Islam et al, 2020 ; Hu et al, 2021b ). Stage information was obtained from the UCSC Xena ( http://xena.ucsc.edu/ ) database for all tumor samples, and we divided the stages into 4.…”

Mendelian Randomization Analysis Suggests No Associations of Herpes Simplex Virus Infections With Multiple Sclerosis

“…Clinical trials of antiviral treatments in MS ( Lycke et al, 1996 ; Bech et al, 2002 ; Friedman et al, 2005 ) were limited when compared with the development of other therapies ( Lizak et al, 2017 ; Islam et al, 2020 ). There are three phase II clinical trials of acyclovir or valacyclovir in MS patients ( Lycke et al, 1996 ; Bech et al, 2002 ; Friedman et al, 2005 ).…”

Application of Sparse Representation in Bioinformatics

“…Common feature extraction methods can be divided into linear and nonlinear transformations. Typical linear feature extraction algorithms include sparse principal component analysis (PCA) ( Min et al, 2018 ; Islam et al, 2020 ), independent component analysis ( Moysés et al, 2017 ), and LDA. Nonlinear transformation methods primarily include neural networks, kernel methods ( Qi et al, 2021b ), manifold learning ( Shen et al, 2017 ), sparse representation ( Min et al, 2017 ), and matrix factorization methods ( Wang et al, 2017 ; Yang et al, 2017 ; Yang and Hu, 2017 ; McCall et al, 2019 ).…”